Published in Gut on April 01, 1993
Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res (2009) 1.91
Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: biomarker for neoplasia risk. Gastroenterology (2008) 1.73
Association between rectal optical signatures and colonic neoplasia: potential applications for screening. Cancer Res (2009) 1.53
Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res (2012) 1.53
Intestinal transplantation in children with chronic intestinal pseudo-obstruction. Gut (1999) 1.52
Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol (1999) 1.43
Effect of cereal fibre source and processing on rectal epithelial cell proliferation. Gut (1997) 1.38
Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening. Gastroenterology (2010) 1.33
Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. Gut (2001) 1.16
Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia. Clin Cancer Res (2009) 1.09
Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification. J Cancer (2013) 1.06
Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Lett (2007) 1.01
Insights into the field carcinogenesis of ovarian cancer based on the nanocytology of endocervical and endometrial epithelial cells. Int J Cancer (2013) 0.97
Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomography. J Biomed Opt (2014) 0.95
Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis. Cancer Lett (2011) 0.95
Optical measurement of rectal microvasculature as an adjunct to flexible sigmoidosocopy: gender-specific implications. Cancer Prev Res (Phila) (2010) 0.93
Spectral slope from the endoscopically-normal mucosa predicts concurrent colonic neoplasia: a pilot ex-vivo clinical study. Dis Colon Rectum (2008) 0.90
Biological mechanisms underlying structural changes induced by colorectal field carcinogenesis measured with low-coherence enhanced backscattering (LEBS) spectroscopy. PLoS One (2013) 0.87
In vivo risk analysis of pancreatic cancer through optical characterization of duodenal mucosa. Pancreas (2015) 0.81
The effect of calcium supplements on rectal mucosal proliferation. Br J Cancer (1995) 0.80
Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29). Nutr Metab (Lond) (2010) 0.78
Field cancerisation in colorectal cancer: a new frontier or pastures past? World J Gastroenterol (2015) 0.77
Effects of calcium and vitamin D3 on transforming growth factors in rectal mucosa of sporadic colorectal adenoma patients: a randomized controlled trial. Mol Carcinog (2013) 0.77
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
The evolution of cancer of the colon and rectum. Cancer (1975) 9.05
Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med (1992) 5.18
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology (1992) 2.78
Colorectal cancer screening. J Natl Cancer Inst (1991) 2.66
Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology (1987) 2.39
Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer (1974) 1.95
Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res (1988) 1.93
Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut (1992) 1.93
Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med (1985) 1.72
Proliferative patterns in colonic mucosa in familial polyposis. Cancer (1975) 1.64
Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res (1988) 1.62
A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst (1991) 1.57
Do all colorectal carcinomas arise in preexisting adenomas? World J Surg (1989) 1.43
Tritiated thymidine (phi p, phi h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res (1983) 1.42
Classification and risk assessment of individuals with familial polyposis, Gardner's syndrome, and familial non-polyposis colon cancer from [3H]thymidine labeling patterns in colonic epithelial cells. Cancer Res (1984) 1.35
Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28
Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res (1991) 1.25
Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology (1991) 1.22
Surveillance intervals after colonoscopic polypectomy. Endoscopy (1982) 1.10
Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. Gut (1989) 1.08
Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology (1989) 1.07
Follow-up of patients with colorectal adenomas. Endoscopy (1985) 1.03
Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res (1990) 1.02
Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel. Cancer (1991) 0.97
Recurrence rates for colorectal polyps. Cancer (1985) 0.96
Effect of calcium supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut (1989) 0.93
Rectal epithelial cell proliferation in a group of young adults. Influence of age and genetic risk for colon cancer. Cancer (1988) 0.90
Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel. Cancer Res (1990) 0.89
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer (1991) 0.89
Follow-up colonoscopy in patients with colorectal adenomatous polyps. Dis Colon Rectum (1987) 0.88
Effects of dietary wheat bran fiber on rectal epithelial cell proliferation in patients with resection for colorectal cancers. J Natl Cancer Inst (1990) 0.87
Rectal epithelial proliferation characteristics of first degree relatives of sporadic colon cancer patients. Cancer Lett (1990) 0.84
Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst (1992) 0.84
Effects of sodium sulfate on fecal pH and proliferation of colonic mucosa in patients at high risk for colon cancer. J Natl Cancer Inst (1990) 0.83
Colorectal polyps: pathologic diagnosis and clinical significance. CA Cancer J Clin (1985) 0.81
Rectal epithelial proliferation in persons post sporadic colorectal neoplasia. Cancer Lett (1991) 0.79
Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum. Gastroenterology (1991) 0.78
Surveillance for colonic polyps. Mt Sinai J Med (1988) 0.78
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity (2001) 5.04
Conversion of diploidy to haploidy. Nature (2000) 3.28
Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology (1992) 2.78
Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res (1995) 2.17
hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes Dev (2001) 2.11
JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A (1999) 2.08
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer (1992) 2.01
Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol (2001) 1.97
Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology (1994) 1.83
Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1. J Biol Chem (1999) 1.62
hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha. EMBO J (1998) 1.60
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet (1999) 1.56
Persistent tubular resistance to aldosterone in infants with congenital hydronephrosis corrected neonatally. J Pediatr (1987) 1.51
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine. J Clin Invest (1996) 1.49
Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet (2000) 1.49
Percutaneous radiofrequency ablation versus surgical radiofrequency-assisted nodulectomy in treatment of small single nodes of hepatocellular carcinoma: our experience. Minerva Chir (2013) 1.44
The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology (1999) 1.43
Epidemiology of cancer of the large bowel--the 12-year experience of a specialized registry in northern Italy. Ital J Gastroenterol Hepatol (1999) 1.43
Direct association of Bloom's syndrome gene product with the human mismatch repair protein MLH1. Nucleic Acids Res (2001) 1.41
Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome. Ital J Gastroenterol Hepatol (1999) 1.41
Appearance of duodenal folds and untreated adult celiac disease. Gastrointest Endosc (1993) 1.39
[Whipple's disease: progress in the diagnosis and review of the literature]. Minerva Med (2002) 1.38
Acute pyelonephritis as a cause of hyponatremia/hyperkalemia in young infants with urinary tract malformations. Pediatr Infect Dis J (1995) 1.22
In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology (1995) 1.21
Revision rotator cuff repair: factors influencing results. J Bone Joint Surg Am (2001) 1.21
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res (2001) 1.20
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer (1997) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med (2004) 1.19
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut (1999) 1.19
Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol (1990) 1.18
Microsatellite instability in multiple colorectal tumors. Int J Cancer (1999) 1.18
Mismatch recognition and DNA-dependent stimulation of the ATPase activity of hMutSalpha is abolished by a single mutation in the hMSH6 subunit. J Biol Chem (2000) 1.18
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer (1996) 1.17
Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis (1999) 1.13
Presynaptic inhibitory muscarinic receptors modulating [3H] acetylcholine release in the rat urinary bladder. J Pharmacol Exp Ther (1986) 1.13
Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer. Fam Cancer (2001) 1.09
Mutation in the magnesium binding site of hMSH6 disables the hMutSalpha sliding clamp from translocating along DNA. J Biol Chem (2000) 1.09
Characteristics of hepatocellular carcinoma in Italy. J Hepatol (1998) 1.08
Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver (1996) 1.07
Letter: follow-up practices in coeliac disease--intestinal biopsy after child-to-adult transition might be useful. Aliment Pharmacol Ther (2014) 1.07
Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology (2001) 1.07
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene (2008) 1.03
Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.02
Colorectal carcinoma in different age groups: a population-based investigation. Am J Gastroenterol (1997) 1.01
Cowden's disease with extensive gastrointestinal polyposis. J Clin Gastroenterol (1994) 1.01
Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res (2001) 1.01
Characterization of prejunctional muscarinic autoreceptors in the guinea-pig trachea. Br J Pharmacol (1991) 1.01
SHOX point mutations and deletions in Leri-Weill dyschondrosteosis. J Med Genet (2002) 1.00
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer (2001) 1.00
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ). Diabetes Nutr Metab (2004) 1.00
Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet (2007) 1.00
Ultrasound and CT findings in two cases of hemangioma of the adrenal gland. J Comput Assist Tomogr (1989) 0.98
Circadian variations of epithelial cell proliferation in human rectal crypts. Gastroenterology (1994) 0.98
Traumatic pseudoaneurysm of the brachial artery. Orthopedics (2000) 0.98
AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors. Neuropharmacology (2007) 0.98
Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis. Cancer Res (2001) 0.97
The evaluation of androgen circulating levels following castration in adult male rats. Exp Clin Endocrinol (1988) 0.97
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype. Ann Oncol (2005) 0.97
Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes (1997) 0.97
Mismatch repair is required for O(6)-methylguanine-induced homologous recombination in human fibroblasts. Carcinogenesis (2000) 0.97
Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology (1998) 0.96
The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation. Exp Cell Res (1995) 0.96
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis (2006) 0.96
Enzymological differences of AChE and diazinon hepatic metabolism: correlation of in vitro data with the selective toxicity of diazinon to fish species. Sci Total Environ (1995) 0.95
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer (1998) 0.95
Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci (2006) 0.94
Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect Prev (1998) 0.93
Coeliac Disease in the Elderly. A multicentre Italian study. Gerontology (2001) 0.93
n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation. Am J Clin Nutr (1996) 0.92
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection. Cancer (1997) 0.92
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer. Eur J Cancer (1997) 0.90
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism. Mediators Inflamm (2013) 0.90
Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol (2001) 0.89
Gross pathologic types of hepatocellular carcinoma in Italy. Oncology (1999) 0.89
Tachykinin-dependent and -independent components of peristalsis in the guinea pig isolated distal colon. Gastroenterology (2001) 0.89
Congenital reflux nephropathy: a follow-up of 108 cases diagnosed perinatally. Br J Urol (1998) 0.89
Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: a population-based investigation. Eur J Cancer (1996) 0.88
Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial. Diabet Med (2005) 0.88
3D finite element non linear analysis on the stress state at bone-implant interface in dental osteointegrated implants. Oral Implantol (Rome) (2011) 0.88
Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors. Neuroscience (2000) 0.88